HYTN — HYTN Innovations Share News
0.000.00%
- CA$11.82m
- CA$12.84m
- CA$1.67m
Brief: Hytn Announces Proposed Spin-Out Of Bpc-157 Peptide Drug Development Business
Brief: HYTN Initiates Sale Of Cannabis Products In Quebec Through Agreement With Rose
Brief: HYTN Announces Launch Of Rapid Onset Nano Gummies And Provides Commercial Update
Brief: Hytn Secures Cannabis Cultivation License To Elevate The Quality Of Its Cannabis Inputs